QURE for Value-Based Care Transformation

Trever is a nationally recognized leader in healthcare strategy and has worked extensively with senior health system leaders across the country on projects ranging from demand forecasting and value-based payment structures to clinical technology assessment and cancer center development. In addition, Trever speaks frequently at national conferences on issues on of quality and value in healthcare.

Before joining QURE, Trever served as Vice President at Sg2 (now a division of MedAssets), a healthcare analytics and intelligence company. At Sg2, Trever led the firm’s Center for Clinical Technology as well as the Oncology Strategy team. Trever holds a PhD from Stanford University in Microbiology and Immunology and received his BS from Brigham Young University.

Czarlota is a practicing internist and subspecializes in nephrology. She oversees quality control of the QURE CPV product and assists in all clinical sciences-related activities.

She holds a degree in Molecular Biology and Biotechnology from the University of the Philippines, with a thesis on DNA vaccine development for dengue fever. She finished medical school at the University of Santo Tomas, graduating cum laude. She completed internal medicine residency and adult nephrology fellowship at the University of the Philippines- Philippine General Hospital. She has a solid background in hemodialysis facility quality assurance and is a visiting faculty at Aesculap Academy, a global interdisciplinary network offering medical training for physicians and allied health professionals. She is a member of the International Society of Nephrology, the Philippine Society of Nephrology, and the Philippine College of Physicians.

David is responsible for planning and executing data analyses related to QURE’s core business, as well as guiding and overseeing the overall analytics and statistical modeling projects of the analytics team.

David received his Master of Public Health from Dartmouth College in 2003, with an emphasis in quality improvement and biostatistics, and a Bachelor of Science in Electrical Engineering from the University of California, Irvine. David has over ten years of experience related to healthcare analysis and outcomes, and he has been a contributing author to over a dozen peer-reviewed articles. Prior to this, he worked in semiconductor technology at IBM, where he fulfilled several technical and information technology roles for US and international clients to enable the success of a multiple projects.